Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy
Search for other papers by Alexis Elias Malavazos in
Google Scholar
PubMed
Search for other papers by Chiara Meregalli in
Google Scholar
PubMed
Search for other papers by Fabio Sorrentino in
Google Scholar
PubMed
Search for other papers by Andrea Vignati in
Google Scholar
PubMed
Search for other papers by Carola Dubini in
Google Scholar
PubMed
Search for other papers by Valentina Scravaglieri in
Google Scholar
PubMed
Search for other papers by Sara Basilico in
Google Scholar
PubMed
Search for other papers by Federico Boniardi in
Google Scholar
PubMed
Search for other papers by Pietro Spagnolo in
Google Scholar
PubMed
Search for other papers by Piergiorgio Malagoli in
Google Scholar
PubMed
Search for other papers by Paolo Romanelli in
Google Scholar
PubMed
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy
Search for other papers by Francesco Secchi in
Google Scholar
PubMed
Search for other papers by Gianluca Iacobellis in
Google Scholar
PubMed
( 1 ). Furthermore, psoriasis may be an independent risk factor for cardiovascular disease (CVD) given their shared inflammatory properties and pathogenic similarities ( 1 ). The inflammatory process in psoriasis can target adipose tissue depots
Search for other papers by Carolina Chaves in
Google Scholar
PubMed
Search for other papers by Mariana Chaves in
Google Scholar
PubMed
Search for other papers by João Anselmo in
Google Scholar
PubMed
Search for other papers by Rui César in
Google Scholar
PubMed
Background Berardinelli–Seip congenital lipodystrophy (BSCL) is a rare disease, with an estimated prevalence of 1 in 10 million worldwide and 1:500 000 cases in Portugal ( 1 ). It is characterized by the absence of subcutaneous adipose tissue
Search for other papers by Fiona Melzer in
Google Scholar
PubMed
Search for other papers by Corinna Geisler in
Google Scholar
PubMed
Department of Medicine 1, Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital of Schleswig-Holstein, Kiel, Germany
Search for other papers by Dominik M Schulte in
Google Scholar
PubMed
Department of Medicine 1, Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital of Schleswig-Holstein, Kiel, Germany
Search for other papers by Matthias Laudes in
Google Scholar
PubMed
Background Lipodystrophy (LD) syndromes are rare heterogeneous disorders with diverse pathophysiology characterized by selective deficiency (partial LD) or complete (total LD) loss of adipose tissue with ectopic lipid accumulation, for example
Search for other papers by P Hanson in
Google Scholar
PubMed
Search for other papers by M Pandit in
Google Scholar
PubMed
Search for other papers by V Menon in
Google Scholar
PubMed
Search for other papers by S Roberts in
Google Scholar
PubMed
Search for other papers by T M Barber in
Google Scholar
PubMed
aetiology of fat necrosis is thought to result from local trauma and tissue injury caused by both physical and chemical insults, stimulating an inflammatory reaction within the adipose tissue (3) . Aseptic saponification of fat by lipases was proposed to be
Search for other papers by Athanasios Fountas in
Google Scholar
PubMed
Search for other papers by Zoe Giotaki in
Google Scholar
PubMed
Search for other papers by Evangelia Dounousi in
Google Scholar
PubMed
Search for other papers by George Liapis in
Google Scholar
PubMed
Search for other papers by Alexandra Bargiota in
Google Scholar
PubMed
Search for other papers by Agathocles Tsatsoulis in
Google Scholar
PubMed
Search for other papers by Stelios Tigas in
Google Scholar
PubMed
Background Lipodystrophy is a rare group of clinically heterogeneous disorders characterized by the complete or partial loss of subcutaneous adipose tissue ( 1 , 2 ). This condition is often accompanied by metabolic complications such as
Search for other papers by Benthe A M Dijkman in
Google Scholar
PubMed
Search for other papers by Christel J M de Blok in
Google Scholar
PubMed
Search for other papers by Koen M A Dreijerink in
Google Scholar
PubMed
Search for other papers by Martin den Heijer in
Google Scholar
PubMed
Background Estradiol is known to be the main initiator of breast development and growth during puberty. Breast maturation following estradiol exposure includes ductal proliferation and accumulation of adipose tissue. Progesterone is known for
Search for other papers by Priya Darshani Chhiba in
Google Scholar
PubMed
Search for other papers by David Segal in
Google Scholar
PubMed
spontaneously over time by avoiding the injection area, which also occurred in our index case. Discussion Lipodystrophy is a disorder of adipose tissue, presenting either as lipohypertrophy or lipoatrophy ( 5 ). Lipoatrophy is defined as a large, often
Search for other papers by Ulla Kampmann in
Google Scholar
PubMed
Search for other papers by Per Glud Ovesen in
Google Scholar
PubMed
Search for other papers by Niels Møller in
Google Scholar
PubMed
Search for other papers by Jens Fuglsang in
Google Scholar
PubMed
. Hyperleptinemia is a result of an increased synthesis and secretion from abundant adipose tissue ( 6 ), but leptin is also secreted in the placenta and leptin levels increase substantially during pregnancy. McIntyre et al. conclude that maternal insulin
Search for other papers by Aysenur Ozderya in
Google Scholar
PubMed
Search for other papers by Sule Temizkan in
Google Scholar
PubMed
Search for other papers by Kadriye Aydin Tezcan in
Google Scholar
PubMed
Search for other papers by Feyza Yener Ozturk in
Google Scholar
PubMed
Search for other papers by Yuksel Altuntas in
Google Scholar
PubMed
supraclavicular area ( Fig. 2 ). Biopsies from these areas were concordant with lipomatous tissue ( Fig. 3 ). An abdominal CT examination revealed an enlarged liver (cranio-caudal axis: 24 cm) and spleen. After a differential diagnosis of the causes of the
Division of Endocrinology and Metabolism, Dokuz Eylul University, Izmir, Turkey
Search for other papers by Baris Akinci in
Google Scholar
PubMed
Search for other papers by Rasimcan Meral in
Google Scholar
PubMed
Search for other papers by Diana Rus in
Google Scholar
PubMed
Search for other papers by Rita Hench in
Google Scholar
PubMed
Search for other papers by Adam H Neidert in
Google Scholar
PubMed
Search for other papers by Frank DiPaola in
Google Scholar
PubMed
Search for other papers by Maria Westerhoff in
Google Scholar
PubMed
Search for other papers by Simeon I Taylor in
Google Scholar
PubMed
Search for other papers by Elif A Oral in
Google Scholar
PubMed
Background Lipodystrophy syndromes are a heterogeneous cluster of diseases characterized by loss of subcutaneous adipose tissue that leads to severe insulin resistance and dyslipidemia. Metreleptin therapy is now an approved treatment for